Pharmaron
30075937.221.33% ( -0.50 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Pharmaron(300759) predict that the Revenue is 3.578 B (+15.48%), Beat estimate;the EBIT is 418.51 M (+15.02%), Miss estimate;the EPS is 0.185 (+6.75%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.58B15.48%
3.51B13.17%
+0.07B2.31%
EBITMiss expectations
0.42B15.02%
0.45B24.88%
-0.04B9.86%
EPSMiss expectations
0.1856.75%
0.2121.18%
-0.025014.43%
Upcoming earnings report - FY2026 Semi-Annual Earning Release
Available dateAug 21, 2026
Estimate Revenue7.57 B
Estimate EBIT914 M
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf